APRIL BAISDEN: Open Payments
NPI 1376763144 · SCOTT DEPOT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152,714 in 179 payments from 12 companies in 2025. Trend: 2023 $135,283 · 2024 $156,503 · 2025 $152,714
Speaker / faculty: $144,570Travel & lodging: $5,100Food & beverage: $3,045
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 114 | $126,604 |
| Vanda Pharmaceuticals Inc. | 33 | $25,627 |
| Alkermes, Inc. | 15 | $138 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| Lundbeck LLC | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Indivior Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: VRAYLAR, FANAPT, LYBALVI, INGREZZA, REXULTI, VIVITROL, COBENFY, SUBLOCADE.
Industry payments across WV — which companies pay providers there.
